Is 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate? Is 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate safe for nursing mother and child? Does 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate extracts into breast milk? Does 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate has any long term or short term side effects on infants? Can 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate influence milk supply or can 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate decrease milk supply in lactating mothers?

• DrLact safety Score for 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate .
• It is recommended to evaluate the advantage of not breastfeeding while using 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate Vs not using 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate And continue breastfeeding.
• While using 5-beta-Diethylaminoethyl-3-phenyl-1,2,4-oxadiazole citrate Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Nonopioid antitussive medication for which there are very few references.It has been a cause of adverse reactions in children. At latest update no published data on excretion into breast milk were found. A known safer alternative should be preferred until more published data on this drug in relation to breastfeeding is available, especially during the neonatal period and in case prematurity.